Botanical species · safety record

Adonis aestivalis

The EFSA Compendium of Botanicals holds 7 constituent measurements and 2 adverse-effect records for Adonis aestivalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Adonis aestivalis L.

7Constituent measurements
2Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Cardenolides1
  • Corytuberine1
  • Cymarin1
  • Helveticoside1
  • Magnoflorine1
  • Periplogenin1
  • Strophantidin1

Plant parts

  • Aerial part of plants7
  • Seed2

Preparations

  • Solvent extraction6
  • Fresh2
  • Drying (dehydration)1

Effect types

  • Digestive1
  • Pulmonary and cardiac1

Target tissues

  • Cardiovascular1
  • Digestive1
  • haematological1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CorytuberineAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
HelveticosideAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MagnoflorineAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
PeriplogeninAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CardenolidesSeedSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
CymarinAerial part of plantsDrying (dehydration)Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
StrophantidinSeedSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveAerial part of plantsFreshHorse (as animal)Case reportResolve DOI
Pulmonary and cardiacCardiovascular / haematologicalAerial part of plantsFreshHorse (as animal)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. KOPP, B., KRENN, L., KUBELKA, E., KUBELKA, W. CARDENOLIDES FROM ADONIS-AESTIVALIS. PHYTOCHEMISTRY, 1992, vol. 31, no. 9, p. 3195-3198. DOI
  2. Slavik, Jiri., Bochorakova, Jitka., Slavikova, Leonora. Occurrence of magnoflorine and corytuberine in some wild or cultivated plants of Czechoslovakia.. Collection of Czechoslovak Chemical Communications, 1987, vol. 52, no. 3, p. 804-11. DOI
  3. KAVALALI, G. ISOLATION OF CYMARIN FROM ADONIS-AESTIVALIS. Lloydia-the journal of natural products, 1973, vol. 36, no. 4, p. 426-426.
  4. Kubo, Satoshi., Kuroda, Minpei., Matsuo, Yukiko., Masatani, Daichi., Sakagami, Hiroshi., Mimaki, Yoshihiro. New Cardenolides from the Seeds of Adonis aestivalis. CHEMICAL & PHARMACEUTICAL BULLETIN, 2012, vol. 60, no. 10, p. 1275-1282.
  5. Woods, LW., Filigenzi, MS., Booth, MC., Rodger, LD., Arnold, JS., Puschner, B. Summer pheasant's eye (Adonis aestivalis) poisoning in three horses. VETERINARY PATHOLOGY, 2004, vol. 41, no. 3, p. 215-220. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue